| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$4,722,549,774 |
|
|
|
Indirect Value
|
$10,449,250 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$4,732,999,024 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
17
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
8.5
|
0.0
|
| Percentage
Gain/Loss : |
 51.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-01-03 |
4 |
B |
$4.85 |
$529,276 |
D/D |
108,339 |
3,002,956 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-05-09 |
4 |
B |
$19.43 |
$543,967 |
D/D |
25,789 |
3,008,716 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-05-11 |
4 |
B |
$20.55 |
$368,922 |
D/D |
17,600 |
3,026,316 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-05-22 |
4 |
B |
$26.15 |
$911,625 |
D/D |
34,728 |
3,061,044 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-05-23 |
4 |
B |
$26.69 |
$1,342,706 |
D/D |
49,200 |
3,110,244 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-08-01 |
4 |
B |
$20.20 |
$3,464,200 |
D/D |
155,486 |
3,265,730 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-08-02 |
4 |
B |
$24.37 |
$1,320,395 |
D/D |
53,000 |
3,318,730 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-08-03 |
4 |
B |
$23.70 |
$1,634,723 |
D/D |
68,964 |
3,387,694 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-09-14 |
4 |
B |
$11.66 |
$2,409,935 |
D/D |
181,620 |
3,569,314 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-02-21 |
4 |
B |
$2.58 |
$1,831,467 |
D/D |
654,619 |
3,657,575 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-09-15 |
4 |
B |
$14.38 |
$3,000,710 |
D/D |
197,098 |
3,766,412 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-09-18 |
4 |
B |
$15.12 |
$474,458 |
D/D |
31,200 |
3,797,612 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-02-21 |
4 |
B |
$2.98 |
$775,491 |
D/D |
250,381 |
3,907,956 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-09-07 |
4 |
B |
$2.50 |
$52,626 |
D/D |
20,433 |
3,928,389 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2007-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,928,389 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-05 |
4 |
A |
$1.38 |
$655,467 |
D/D |
474,976 |
4,403,365 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-06 |
4 |
A |
$1.63 |
$278,782 |
D/D |
171,032 |
4,574,397 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-09 |
4 |
A |
$1.64 |
$197,525 |
D/D |
120,442 |
4,694,839 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-23 |
4 |
B |
$1.70 |
$139,431 |
D/D |
82,018 |
4,776,857 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-24 |
4 |
B |
$1.87 |
$71,060 |
D/D |
38,000 |
4,814,857 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-25 |
4 |
B |
$1.74 |
$174 |
D/D |
100 |
4,814,957 |
3.84 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-26 |
4 |
B |
$1.71 |
$27,873 |
D/D |
16,300 |
4,831,257 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-08-21 |
4 |
B |
$1.60 |
$265,667 |
D/D |
166,042 |
4,997,299 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-08-22 |
4 |
B |
$1.60 |
$1,920 |
D/D |
1,200 |
4,998,499 |
3.84 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-09-05 |
4 |
B |
$2.47 |
$187,881 |
D/D |
76,065 |
5,074,564 |
3.92 |
- |
|
318 Records found
|
|
Page 9 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
